pipette
ESEspañol

H3K9 demethylase KDM3A potentiates interferon signaling and macrophage-driven inflammation in atherosclerosis

Ricky Siebeler, Hung‐Jen Chen, Tatyana Kuznetsova, Annette E. Neele, Saskia van der Velden, Marion J. Gijbels, Guillermo R. Griffith, Cindy P. A. A. van Roomen, Koen H.M. Prange, Marieke C.S. Boshuizen, Tom T. P. Seijkens, Kaylin C.A. Palm, Michal Mokrý, Esther Lutgens, Marten A. Hoeksema, Menno P.J. de Winther

Peer-reviewed journal

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Together, these findings establish KDM3A as an epigenetic regulator that sustains IFN-driven macrophage activation and promotes progression of atherosclerosis, nominating KDM3A as a potential target for selectively modulating IFN-dependent inflammation.

Appeared: Sunday, November 15. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aei2659